Tarsons products limited is a major Indian life sciences business that designs, develops, manufactures, and markets consumables, reusables, and other products, including benchtop equipment. Tarsons Products IPO will hit the market in 15 November 2021.
Table of Contents
About the company
Tarsons products limited manufacture a variety of high-quality labware that aids scientific research and improves healthcare.
They have a broad product range with approximately 1,700 SKUs throughout 300 products as of March 31, 2021.
Consumables, reusables, and others are the three main segments in which their product offering is divided.
Products in the ‘Consumables’ section comprise centrifuge ware, cryogenic ware, liquid handling, PCR consumables, petri dish, transfer pipettes, and other items.
Bottles, carboys, beakers, measuring cylinders, and tube racks are all included in the ‘Reusables’ section.
Benchtop instruments including vortex shakers, centrifuges, pipettors, and others are included in the ‘Others’ section.
Clients
We serve a wide spectrum of end clients from a variety of industries, including research organisations, academic institutions, pharmaceutical firms, contract research organisations (CROs), diagnostic businesses, and hospitals.
- Indian Institute of Chemical Technology, National Centre for Biological Sciences across academic institutes and research organizations.
- Dr Reddy’s Laboratories, Enzene Biosciences across pharmaceutical sectors.
- Syngene International, Veeda Clinical Research across CROs.
- Molbio Diagnostics, Agappe Diagnostic, Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors including diagnostics.
Manufacturing Facilities
Their five production plants in West Bengal are now in operation. They think that their Firm has been able to provide a secure, reliable, and cost-effective way of doing research for the scientific community by concentrating on rigorous quality requirements throughout production processes.
These plants are vertically integrated and have automated assistance systems that help them maintain quality, enhance output, and cut costs.
ISO 9001:2015 and ISO 13485:2016/NS-EN ISO 13485:2016 certifications are held by their major production sites.
In furthermore, their micro and macro tips, cryo vials, and centrifuge tubes have all gained CE-IVD certification.
Tarsons Products IPO
Tarsons products limited, headquartered in Kolkata has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of 150 Crore & 1.32 Crore equity shares on 10 August 2021.
The Offer includes 150 Crore value fresh equity shares and There is an offer for sell(OFS) of 1.32 Crore equity shares by the promoters mentioned in the DRHP.
They are now waiting for approval from Securities and Exchange Board of India(SEBI) to float the initial public offering (IPO) in the market.
Financials Trends
| Particulars | For the year/period ended ( in Cr.) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 295.95 | 248.71 | 211.96 | ||
| Total Revenue | 234.29 | 180.05 | 184.72 | ||
| Profit After Tax | 68.87 | 40.53 | 38.96 | ||
Basic and Diluted Earnings Per Share
| Financial Period | Basic EPS (in INR) | Diluted EPS (in INR) | Weight |
| Financial Year 2021 | 13.43 | 13.43 | 3 |
| Financial Year 2020 | 7.94 | 7.75 | 2 |
| Financial Year 2019 | 7.65 | 7.50 | 1 |
| Weighted Average | 10.64 | 10.55 |
Objects of the Issue
- Prepayment / repayment of all or a portion of the outstanding borrowings of the company to be availed on consolidated basis.
- To meet common corporate objectives.
Basis of the offer
The following are some of the basic criteria and key strengths that contribute into determining the Offer Price:
- With great brand awareness and high-quality goods, India’s leading life sciences supplier.
- Their broad variety of labware items appeals to a wide range of customers.
- Working in a market with a big addressable market and long-term connections with important end customers.
- Production plants that are well-equipped and mechanised.
- Their robust sales and distribution network allows them to reach a wide geographic audience.
- A seasoned promoter with a solid management staff.
Tarsons Products IPO Peer Comparison
There are no publicly traded companies with a portfolio of products or services equivalent to theirs, or a scale of operations comparable to theirs.
Tarsons Products IPO Details
| IPO Opening Date | 15 November 2021 |
| IPO Closing Date | 17 November 2021 |
| Issue Type | Book Built |
| Face Value | 10 per share |
| IPO Price | 635 to 662 per equity share |
| Market Lot | 22 |
| Min Order Quantity | 22 |
| Listing At | BSE, NSE |
| Issue Size | 873.74 Crores |
| Fresh Issue | 150 Crore |
| Offer for Sale | 1.32 Crore equity shares |
Tarsons Products IPO Date
Tarsons Products IPO opening date is 15 November 2021 and the closing date is 17 November 2021. The issue may list on 26 November 2021 .
| IPO Open Date | 15 November 2021 |
| IPO Close Date | 17 November 2021 |
| Basis of Allotment Date | 23 November 2021 |
| Initiation of Refunds | 24 November 2021 |
| Credit of Shares to Demat Account | 25 November 2021 |
| IPO Listing Date | 26 November 2021 |
Basis of Allotment
| Type | % of Offer | Basis of Allotment |
|---|---|---|
| Qualified Institutional Buyer | 50 |
Roughly
equivalent
|
| Non Institutional Investor | 15 |
Roughly
equivalent
|
| Retail | 35 | Minimum level of 1 lot, based on availability, for every shareholder. |
Tarsons Products IPO Allotment Status
Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.
Here, you can find the Allotment Status of Tarsons Products IPO .
Tarsons Products IPO GMP
Tarsons Products IPO Grey Market Premium is 178.
| Date | GMP (in Rs) | Subject to Sauda | Kostak (in Rs) |
| 25 November 2021 | 178 | 2900 | 300 |
| 18 November 2021 | 207 | 3400 | 350 |
| 17 November 2021 | 202 | 2100 | 200 |
| 16 November 2021 | 212 | 5300 | 500 |
| 15 November 2021 | 185 | 4600 | 450 |
| 14 November 2021 | 165 | 3900 | 400 |
| 13 November 2021 | 158 | 3200 | 300 |
| 12 November 2021 | 155 | 4100 | 400 |
| 11 November 2021 | 162 | 3600 | 350 |
| 10 November 2021 | No Trade | No Trade | No Trade |
| 09 November 2021 | No Trade | No Trade | No Trade |
Tarsons Products IPO Review
Tarsons Products IPO is good for long term investors. However, listing gains are not expected from this IPO. The IPO may get listed +- 10% to the price band fixed by the company.
Tarsons Products IPO Risk
- Any disruption, stoppage, or reduction in the availability of raw materials used to make their goods might have a negative impact on their company.
- One of their production sites is located on property for which the company has not acquired all of the necessary permits, and as a result, it may face regulatory action and litigation.
- Their projected capacity expansion plans for their manufacturing units involve the risk of unforeseen implementation delays and cost overruns.
- They might not be able to effectively safeguard or exploit their intellectual property in the future.
- A substantial loss of clients or a drop in orders from a considerable number of customers might result in a fall in their net revenues.
Other Threats
- The COVID-19 pandemic has the potential to have a significant and negative impact on their business.
- Many countries have joined the campaign to prohibit plastic items, including India. It might have a significant and negative impact on their business.
- Failure to satisfy their commitments, such as financial and other covenants under their debt financing agreements, might have a negative impact on their business.
- Exchange rate changes may have an impact on their financial performance.
- They have engaged in linked party transactions in the past and may do so again in the future.
- The selling promoters will receive the funds from the Offer for Sale portion of the Offer immediately.
Tarsons Products IPO Brokerage views
- Yes Securities : Not Updated
- Choice Brokering: Not Updated
- Axis Securities: Not Updated
- IIFL Securities: Not Updated
- Trade swift: Not Updated
- Anand Rathi : Not Updated
- ICICI Securities: Not Updated
Tarsons Products IPO Subscription Status
| Date | Day | QIB | NII | Retail | Employees | Total Subscription |
| 15 November 2021 | 1 | 0.00 | 0.17 | 2.12 | 0.41 | 1.09 |
| 16 November 2021 | 2 | 1.30 | 3.98 | 4.74 | 1.08 | 3.58 |
| 17 November 2021 | 3 | 115.77 | 184.58 | 10.56 | 1.83 | 77.49 |
Promoters
- Sanjive Sehgal
- Rohan Sehgal
Promoter Holding
| Pre Issue Share Holding | 50.97% |
| Post Issue Share Holding |
Tarsons Products IPO Prospectus
Contact Details
Tarsons Products Limited
Martin Burn Buisness Park, Room No. 902 BP- 3, Salt Lake,
Sector- V, Kolkata 700091, West Bengal, India
Telephone: +91 33 3522 0300
E-mail: [email protected]
Website: www.tarsons.com
Registrar
KFin Technologies Private Limited
Selenium Tower-B,
Plot 31 & 32, Financial District,
Nanakramguda, Serilingampally,
Hyderabad, Telangana 500032, India
Tel: (91 40) 6716 2222, 1800 309 4001
E-mail: [email protected]
Website: www.kfintech.com
Lead Manager(s)
- ICICI Securities Limited
- Edelweiss Financial Services Limited
- SBI Capital Markets Limited
We hope we are able to answer all your questions about Tarsons Products IPO. If you don’t have a Demat account, open it now with Zerodha best trading app.
Disclaimer
The reference of IPO Grey Market Premium (IPO GMP) is only valid for the date specified in the header.
On the IPO Grey Market, we do not purchase or sell IPO forms.
The Kostak Rate is the profit earned by selling an IPO application (in an off-market transaction) to somebody else before the issue is allotted or listed.
Do not subscribe to an IPO based solely on the premium price, as it may alter at any time before to the listing. Only consider the fundamentals of the companies when subscribing.
The GMP rates for IPOs are based on market intelligence. Please keep in mind that these IPO GMP rates may vary by geography and market.
Note:
We do not engage in grey market trading or facilitate the purchase or sale of IPO forms.
What is grey Market?
The phrase “grey market” refers to an illegal over-the-counter market where IPO applications and IPO stock are traded before the entity is listed on a stock exchange. This is a technique for dealers to help consumers who wish to sell their home before it goes on the market.
This is also a way to increase the listing fee and provide help for the issue prior to the listing. In the IPO grey market, there are two types of transactions that take place:
- IPO stocks are traded at a premium in the grey market.
- At a kostak, an IPO application is traded.
What is grey Market Premium?
The Grey Market Premium, or GMP, is the price at which IPO stock shares are exchanged in the grey market.
This could be correct or incorrect, implying that the grey market trading price is greater or cheaper than the issue price, depending on demand and supply for the stocks.
Typically, individuals who do not want to incur the risk of their shares not being allocated through an IPO can purchase shares on the grey market in the hopes of flipping them on the IPO for a profit.
What is Kostak?
The additional amount in rupees at which IPO applications are sold in the IPO Grey Market is known as kostak (or price of application). The bonus of a maximum lot retail application in an IPO is generally described as the ‘Kostak’ value.
The Kostak price is significant primarily before the offer is closed for subscription and the ultimate bidding status is made accessible to IPO participants. After the final auction status is known to investors, only a small percentage of IPO applications are exchanged.
‘Kostak’ is made for those who do not want to incur a risk on an IPO or gain from a listing.
Example:
Tarsons Products IPO
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720
This means Tarsons Products IPO of Rs 13770 are being traded in IPO Grey Market at Rs 680 to Rs 720.
Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.
Kostak rate
The Kostak rate is the fee received by an investor who sells his or her IPO application on the grey market. Regardless of allotment status, this is the money an individual stands to gain.
Subject to Sauda
The money that an investor stands to gain by selling his or her application for firm allotment is referred to as the subject to Sauda. Firm allocation is the important operative phrase here. The sauda will be cancelled if the applicant is not allotted.
When selling an IPO application in the grey market, the client and seller agree that the sale will only be legal if the seller receives the allocation. The deal is avoided if the seller does not get any stocks throughout the IPO procedure.
FAQ
Tarsons Products IPO Opening Date?
Tarsons Products IPO will open in 15 November 2021.
Tarsons Products IPO Listing Date?
Tarsons Products IPO will list in 26 November 2021.
Tarsons Products IPO GMP Today?
Tarsons Products IPO Grey Market Premium is INR 178.
Tarsons Products IPO Allotment Date?
Tarsons Products IPO basis of allotment will be in 24 November 2021.
Lot size for Tarsons Products IPO ?
Lot size for Tarsons Products IPO is 22.
